Finsbury Worldwide Pharm Tst PLC
14 December 2001
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
Finsbury Worldwide Pharmaceutical Trust PLC
2) Name of shareholder having a major interest
Church Commissioners for England
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them
Chase (GIS) Nominees Limited
5) Number of shares/amount of stock acquired
N/A
6) Percentage of issued class
N/A
7) Number of shares/amount of stock disposed
100,000
8) Percentage of issued class
0.25%
9) Class of security
Ordinary shares of 25p each
10) Date of transaction
13 December 2001
11) Date company informed
14 December 2001
12) Total holding following this notification
1,100,000
13) Total percentage holding of issued class following this notification
2.82%
Close Finsbury Asset Management Limited
Secretary
14 December 2001
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.